These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20100034)

  • 21. Effect of sampling volume on dry powder inhaler (DPI)-emitted aerosol aerodynamic particle size distributions (APSDs) measured by the Next-Generation Pharmaceutical Impactor (NGI) and the Andersen eight-stage cascade impactor (ACI).
    Mohammed H; Roberts DL; Copley M; Hammond M; Nichols SC; Mitchell JP
    AAPS PharmSciTech; 2012 Sep; 13(3):875-82. PubMed ID: 22678745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technical features of vaping drug delivery system for bronchodilator delivery.
    Chaoui M; Perinel-Ragey S; Prévôt N; Leclerc L; Pourchez J
    Int J Pharm; 2022 Nov; 628():122350. PubMed ID: 36374741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aerodynamic characteristics of a dry powder inhaler at low inhalation flows using a mixing inlet with an Andersen Cascade Impactor.
    Nadarassan DK; Assi KH; Chrystyn H
    Eur J Pharm Sci; 2010 Mar; 39(5):348-54. PubMed ID: 20093182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro aerodynamic characteristics of aerosol delivered from different inhalation methods in mechanical ventilation.
    ElHansy MHE; Boules ME; Farid H; Chrystyn H; El-Maraghi SK; Al-Kholy MB; El-Essawy AFM; Abdelrahman MM; Said ASA; Hussein RRS; Rabea H; Abdelrahim MEA
    Pharm Dev Technol; 2017 Sep; 22(6):844-849. PubMed ID: 27493018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How Cold Is Cold Enough? Refrigeration of the Next-Generation Impactor to Prevent Aerosol Undersizing.
    Schuschnig U; Heine B; Knoch M
    J Aerosol Med Pulm Drug Deliv; 2022 Jan; 35(1):25-31. PubMed ID: 34097468
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhalation performance of pollen-shape carrier in dry powder formulation: effect of size and surface morphology.
    Hassan MS; Lau R
    Int J Pharm; 2011 Jul; 413(1-2):93-102. PubMed ID: 21540087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol.
    David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S
    AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next generation pharmaceutical impactor: a new impactor for pharmaceutical inhaler testing. Part III. extension of archival calibration to 15 L/min.
    Marple VA; Olson BA; Santhanakrishnan K; Roberts DL; Mitchell JP; Hudson-Curtis BL
    J Aerosol Med; 2004; 17(4):335-43. PubMed ID: 15699634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.
    Kamiya A; Sakagami M; Byron PR
    J Pharm Sci; 2009 Mar; 98(3):1028-39. PubMed ID: 18661538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow.
    Abdelrahim ME; Assi KH; Chrystyn H
    Pharm Dev Technol; 2013; 18(4):944-9. PubMed ID: 21981637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhalation performance of pollen-shape carrier in dry powder formulation with different drug mixing ratios: comparison with lactose carrier.
    Hassan MS; Lau R
    Int J Pharm; 2010 Feb; 386(1-2):6-14. PubMed ID: 19922775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
    Rehman M; Shekunov BY; York P; Lechuga-Ballesteros D; Miller DP; Tan T; Colthorpe P
    Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration.
    Marple VA; Olson BA; Santhanakrishnan K; Mitchell JP; Murray SC; Hudson-Curtis BL
    J Aerosol Med; 2003; 16(3):301-24. PubMed ID: 14572327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of dry powder inhaler (DPI) resistance and aerosol dispersion timing on emitted aerosol aerodynamic particle sizing by multistage cascade impactor when sampled volume is reduced from compendial value of 4 L.
    Mohammed H; Arp J; Chambers F; Copley M; Glaab V; Hammond M; Solomon D; Bradford K; Russell T; Sizer Y; Nichols SC; Roberts DL; Shelton C; Greguletz R; Mitchell JP
    AAPS PharmSciTech; 2014 Oct; 15(5):1126-37. PubMed ID: 24871551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The function profile of compressed-air and ultrasonic nebulizers.
    Wu HL; Lin YZ; Wu WF; Huang FY
    Acta Paediatr Taiwan; 2003; 44(5):264-8. PubMed ID: 14964980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation.
    Ari A; Atalay OT; Harwood R; Sheard MM; Aljamhan EA; Fink JB
    Respir Care; 2010 Jul; 55(7):845-51. PubMed ID: 20587095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adapting the Abbreviated Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to compare with clinical data: a scoping study with the "Alberta" idealized throat (AIT) inlet.
    Mitchell J; Copley M; Sizer Y; Russell T; Solomon D
    J Aerosol Med Pulm Drug Deliv; 2012 Aug; 25(4):188-97. PubMed ID: 22857270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A methodology to study impactor particle reentrainment and a proposed stage coating for the NGI.
    Rissler J; Asking L; Dreyer JK
    J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):309-16. PubMed ID: 19415989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines.
    Wong W; Crapper J; Chan HK; Traini D; Young PM
    J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.